ORCL Form 144: Insider plans 8,000-share sale via Wells Fargo on 09/12/2025

Rhea-AI Filing Summary

This Form 144 notice shows a proposed sale of 8,000 shares of common stock of Oracle Corporation (ORCL) through Wells Fargo Clearing Services, with an aggregate market value of $2,430,857 and an approximate sale date of 09/12/2025. The filer reports acquiring these shares on 05/31/2019 as grants and RSUs awarded by the issuer, with payment recorded on the acquisition date.

The filing also discloses a sale in the past three months: 3,500 shares sold on 09/12/2025 generating $1,071,000 in gross proceeds. Outstanding shares are listed as 2,841,714,000, indicating the proposed sale represents a de minimis percentage of the company's total shares.

Insights

Securities Analyst

Routine insider sale; immaterial to market cap given small share fraction.

The notice documents an insider-originated sale of 8,000 common shares via Wells Fargo, acquired as RSUs in 2019. With outstanding shares of 2,841,714,000, the sale equals a negligible fraction of float and is unlikely to affect ORCL's market valuation or liquidity. The recent 3,500-share sale for $1,071,000 appears consistent with scheduled disposals of vested equity rather than a signal of operational or financial distress. This is a customary disclosure under Rule 144.

Corporate Governance Expert

Disclosure complies with Rule 144; no governance red flags evident from this filing alone.

The form states the securities were received as grants/RSUs from the issuer and were acquired in 2019, with planned sales executed through a broker. The filer affirms no undisclosed material information. There are no indications of unexpected executive departures, related-party transactions, or exceptions to required disclosures. From a governance perspective, this is a standard notification of insider share disposition.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Wells Fargo Clearing Services 1 North Jefferson Avenue St. Louis MO 63103	8000	2430857.00	2841714000	09/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	05/31/2019	Grants & RSUs	Issuer			8000	05/31/2019	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
William G Parrett 2300 Oracle Way Austin TX 78741	Oracle Corporation	09/12/2025	3500	1071000.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Oracle's (ORCL) Form 144 filed here report?

The filing reports a proposed sale of 8,000 common shares valued at $2,430,857, with an approximate sale date of 09/12/2025.

How were the 8,000 ORCL shares acquired?

The shares were acquired on 05/31/2019 as grants and RSUs from the issuer, with payment recorded on that acquisition date.

Does the filing show any recent sales by the same person?

Yes. It discloses a sale of 3,500 shares on 09/12/2025 that generated $1,071,000 in gross proceeds.

Through which broker will the proposed sale be executed?

The proposed sale is to be executed through Wells Fargo Clearing Services (broker address listed in the filing).

How large is this sale relative to Oracle's outstanding shares?

The filing lists 2,841,714,000 shares outstanding; 8,000 shares represent a negligible fraction of total outstanding stock.